![](https://nordot-res.cloudinary.com/c_limit,w_800,f_auto,q_auto:eco/ch/images/1169362790728007898/origin_1.jpg)
Novavax (NASDAQ:NVAX) has outperformed the market over the past 5 years by 5.74% on an annualized basis producing an average annual return of 18.97%. Currently, Novavax has a market capitalization of $2.22 billion.
Buying $100 In NVAX: If an investor had bought $100 of NVAX stock 5 years ago, it would be worth $251.51 today based on a price of $15.04 for NVAX at the time of writing.
Novavax's Performance Over Last 5 Years
![](https://nordot-res.cloudinary.com/c_limit,w_800,f_auto,q_auto:eco/ch/images/1169362790063276045/origin_1.png)
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.